NovaBridge Biosciences (NBP) Receivables - Net (2018 - 2023)

NovaBridge Biosciences (NBP) has 6 years of Receivables - Net data on file, last reported at $743603.1 in Q4 2023.

• Receivables - Net for Q4 2023 came in at $743603.1, down 79.24% year-over-year; the trailing twelve-month figure through Dec 2023 was $743603.1 (down 79.24% YoY), and the FY2023 annual result was $743603.1, up 126.99% from the prior year.
• Receivables - Net eased to $743603.1 in Q4 2023 per NBP's latest filing, from $3.6 million in the prior quarter.
• Over five years, Receivables - Net peaked at $3.6 million in Q4 2022 and troughed at $76000.0 in Q2 2022.
• A 5-year average of $1.1 million and a median of $724801.6 in 2021 frame the typical range for Receivables - Net.
• The sharpest annual moves came in 2020 and 2022: Receivables - Net jumped 231.71% in 2020, then tumbled 89.24% in 2022.
• A 5-year view of Receivables - Net shows it stood at $556172.6 in 2019, then soared by 215.61% to $1.8 million in 2020, then dropped by 17.88% to $1.4 million in 2021, then jumped by 148.44% to $3.6 million in 2022, then slumped by 79.24% to $743603.1 in 2023.
• Business Quant data shows NBP's Receivables - Net at $743603.1 in Q4 2023, $3.6 million in Q4 2022, and $76000.0 in Q2 2022.